Calls made through the app display the practice’s designated office number, maintaining professional boundaries and presenting patients with a number they are likely to recognize and trust.
Together, Gillette and Lay-Up aim to provide the children and youth Lay-Up serves with access to positive role models while fostering the development of young basketball coaches, shaping them into impactful leaders both on and off the court.
For more than two decades, Michael served as the president of the American Herbal Products Association (AHPA), where he was a tireless champion for consumer access, industry best practices, and broader appreciation for the role of botanicals in better health.
Starting later this month, Simply Pop will be available to consumers on the West Coast and in the Southeast on the U.S
“Since creating the wound care category more than 100 years ago, we’ve been staying on top of trends — consistently evolving our innovation pipeline to remain relevant with new and loyal audiences,” says Steven Maseda, head of U.S. wound care at Kenvue.
If approved, Dupixent would be the first and only targeted medicine to treat BP in the US; FDA decision expected by June 20, 2025.
David Pinto writes that surprising to some and not so surprising to others was the absence of any drug chain from the list.
happy's rapid and strategic growth has resulted in the brand's presence in more than 60,000 points of distribution in popular big-box retailers, regional grocery stores, and e-commerce platforms.
By Micah Cost, CEO, Pharmacy Quality Alliance (PQA)
By Sandra Hanna, CEO Neighbourhood Pharmacies.
Ana Archbold is responsible for setting and executing the broader strategy for the company’s Self-Care and Wellness division in the U.S.
Walgreens chief executive Officer Tim Wentworth said on an earnings call last month that the company plans to divest VillageMD and use any proceeds to reduce debt and improve its balance sheet.
According to the Kinsa Illness report, the percentage of positive influenza cases is above levels observed this time last year. Flu A has dominated the season with the highest reports being observed in the pediatric population
According to IQVIA sales data for the 12-month period ending December 2024, the Evoclin Foam, 1% market achieved annual sales of approximately $5.8 million.
The uptick in product introductions is a sign of retail recovery, and thus far there are similarities in launch patterns in 2025.
For 11 years, the Walgreens Flu Index has provided an early and accurate view of disease trends. The last four consecutive weeks of data have shown increasing flu activity across the U.S.
